References
- Rejeski W J, Brawley L R, Shumaker S A. Physical activity and health related quality of life. Exerc Sport Sci Rev 1996; 24: 71–108
- Bhattacharya S M. Effects of Tibolone on health-related quality of life in menopausal (surgical) woman. Int J Gynecol Obstet 2007; 99: 43–45
- Schneider H PG, Heinemann L AJ, Rosemeler H P, Potthoff P, Behre H M. The menopause rating scale (MRS): reliability of scores of menopausal complaints. Climacteric 2000; 3: 59–64
- Schneider H PG, Heinemann L AJ, Thiele K. The menopause-rating scale (MRS): cultural and linguistic translation into English. Life Med Sci Onlines 2002; 3, DOI:10.1072/LO0305326
- Gulseren L, Kalafat D, Mandaci H, Gulseren S, Camil L. Effects of Tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow up study. Aust NZ J Obstet Gynaecol 2005; 45: 71–73
- Rannestad T. Hysterectomy: effects on quality of life and psychological aspects. Best Pract Res Clin Obstet Gynecol 2005; 19: 419–430
- Altman N, Sachar E J, Gruen P H, Halpern F S, Eto S. Reduced plasma LH concentration in postmenopausal depressed women. Psychosom Med 1975; 37: 274–276
- Halbreich U, Kahn L S. Role of oestrogen in the aetiology and treatment of mood disorders. CNS Drugs 2001; 15: 797–817
- Young E, Korszun A. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis. Psychiatr Clin North Am 1998; 21: 309–323
- Harlow B L, Wise L A, Otto M W, Soares C N, Cohen L S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard study of moods and cycles. Arch Gen Psychiatry 2003; 60: 29–36
- Freeman E W, Sammel M D, Liu L, Gracia R C, Nelson D B, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61: 62–70
- Gould E, Tanapat P, Rydel T, Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 2000; 48: 715–720